Evidence map›Paper›PMID 40278904›Full record

ReviewCell and tissue research2025

Olfactory receptors and human diseases.

Zhong-Qi Yuan, Xiao-Chun Peng, Lian Liu, Fu-Yuan Yang, Feng Qian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cell and tissue research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Olfactory Decline in Elderly at High Altitudes: A Narrative Review.International journal of general medicine · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhong-Qi YuanDepartment of Neurosurgery, Health Science Center, First Affiliated Hospital of Yangtze University, Yangtze University, Hubei Province, Jingzhou, 434023, China.
Xiao-Chun PengDepartment of Pathophysiology, School of Basic Medicine, Health Science Center, Yangtze University, Hubei Province, Jingzhou, 434023, China.
Lian LiuDepartment of Pharmacology, Health Science Center, Jingzhou Hospital Affiliated to Yangtze University, Yangtze University, Hubei Province, Jingzhou, 434023, China.
Fu-Yuan YangDepartment of Physiology, School of Basic Medicine, Health Science Center, Yangtze University, Hubei Province, Jingzhou, 434023, China.
Feng QianDepartment of Neurosurgery, Health Science Center, First Affiliated Hospital of Yangtze University, Yangtze University, Hubei Province, Jingzhou, 434023, China. qianfeng@yangtzeu.edu.cn.

Funding

Central Guiding Local Science and Technology Development Fund Project XZ202401YD0002CNature Science Foundation of Hubei Province 2023AFB839Wujieping Medical Foundation - Digestive Tract Cancer Research Fund 320.6750.2024-10-3
6 · The paper itself

Abstract

Olfaction plays a crucial role in distinguishing odors, enabling organisms to seek benefits and evade hazards. Olfactory receptors (ORs), characterized by highly variable binding pockets, facilitate the detection of diverse odorants from both external and internal environments. Nasal ORs, expressed in olfactory sensory neurons (OSNs), are critical for olfactory cognition and associated neuronal plasticity. In contrast, extra-nasal ORs, expressed in extra-olfactory tissues, detect specific chemicals and modulate cellular processes such as proliferation, migration, inflammation, and apoptosis. Aberrant OR expression or dysfunction has been implicated in numerous human diseases, including anosmia, dementia, dermatopathies, obesity, infertility, cancers, respiratory disorders, atherosclerosis and viral infections. Olfactory training, such as aromatherapy, demonstrates significant therapeutic potential for anosmia, dementia and psychological distress. Natural or synthetic odorants have been applied for promoting hair regeneration and cutaneous wound healing. Conversely, overexpression of specific ORs in cancer cells may drive tumor progression. Additionally, ORs may mediate virus-host interactions during infection, owing to their structural variability. Collectively, OR-targeted agonists and antagonists (odorants) represent promising candidates for treating OR-associated pathologies.

Indexed as

Olfactory Receptor NeuronsReceptors, OdorantAnimalsHumansReceptors, OdorantAnosmiaCancerOdorantOlfactory receptorVirus infection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.